| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.527 | 16.698 | 18.158 | 16.041 | 20.155 | 25.270 | 39.875 | 55.789 | 26.014 | 23.023 |
| Total Income - EUR | 24.529 | 16.700 | 18.159 | 16.043 | 20.159 | 25.272 | 39.881 | 55.806 | 74.556 | 67.275 |
| Total Expenses - EUR | 9.883 | 10.366 | 11.714 | 12.715 | 17.835 | 17.525 | 18.696 | 28.338 | 39.401 | 48.552 |
| Gross Profit/Loss - EUR | 14.647 | 6.334 | 6.445 | 3.328 | 2.324 | 7.747 | 21.185 | 27.468 | 35.155 | 18.723 |
| Net Profit/Loss - EUR | 13.910 | 6.167 | 6.263 | 3.168 | 2.122 | 7.510 | 20.786 | 26.938 | 34.939 | 17.579 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 |
Check the financial reports for the company - Marco Medvet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 29.389 | 4.207 | 10.613 | 13.074 | 6.410 | 14.230 | 24.996 | 36.435 | 52.807 | 30.607 |
| Inventories | 6 | 0 | 0 | 0 | 10 | 10 | 10 | 335 | 448 | 489 |
| Receivables | 783 | 1.736 | 3.079 | 223 | 219 | 7.057 | 11.126 | 19.496 | 33.914 | 15.882 |
| Cash | 28.600 | 2.471 | 7.535 | 12.851 | 6.182 | 7.163 | 13.860 | 16.604 | 18.445 | 14.236 |
| Shareholders Funds | 27.763 | 2.026 | 8.255 | 11.271 | 3.903 | 7.618 | 20.957 | 27.074 | 44.544 | 17.848 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.459 | 2.250 | 1.769 | 1.803 | 2.555 | 6.597 | 4.024 | 9.346 | 8.248 | 12.744 |
| Income in Advance | 186 | 184 | 657 | 0 | 0 | 62 | 61 | 61 | 61 | 60 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Marco Medvet Srl